Literature DB >> 12837820

Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?

Dan L Longo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12837820     DOI: 10.1093/jnci/95.13.928

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies.

Authors:  Matthew Koshy; Shayna E Rich; Usama Mahmood; Young Kwok
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-27       Impact factor: 7.038

2.  Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.

Authors:  Moo-Kon Song; Joo-Seop Chung; Je-Jung Lee; Shin Young Jeong; Sang-Min Lee; Jun-Shik Hong; Ari Chong; Joon-Ho Moon; Ji-Hyun Kim; Seok-Mo Lee; Seong Jang Kim; Ho-Jin Shin
Journal:  Cancer Sci       Date:  2013-10-23       Impact factor: 6.716

Review 3.  Nonclonal Chromosome Aberrations and Genome Chaos in Somatic and Germ Cells from Patients and Survivors of Hodgkin Lymphoma.

Authors:  Sara Frias; Sandra Ramos; Consuelo Salas; Bertha Molina; Silvia Sánchez; Roberto Rivera-Luna
Journal:  Genes (Basel)       Date:  2019-01-10       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.